Explore
MedicinePOM

Azacitidine

A chemotherapy medicine given by injection for myelodysplastic syndrome and certain leukaemias.

Clinical information

Common uses

  • myelodysplastic syndrome (MDS) in adults
  • chronic myelomonocytic leukaemia
  • juvenile myelomonocytic leukaemia in children

Common side effects

  • feeling sick and vomiting
  • low blood counts (anaemia, low platelets, low white cells)
  • fever
  • diarrhoea or constipation
  • redness at the injection site

Cautions

  • blood counts checked often — can cause severe blood-cell drops
  • can cause serious or fatal tumour lysis syndrome
  • extra risk with severe liver disease; kidney monitoring needed
  • must not be swapped with oral azacitidine tablets

Pregnancy: can harm the baby — avoid; use effective contraception

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, VIDAZA (azacitidine for injection) label, setid 3495a71a-cc04-4776-851f-f185956f32af (accessed 2026-08-16)

Approved brands & formulations1

Brand nameDosage formStrengthImporterCategory
AVOXREDParenteral ( Powder for injection )100mg/vialState Trading Organization PlcPOM
Old search API